Silva, E. M., Mariano, V. S., Pastrez, P. R. A., Pinto, M. C., Castro, A. G., Syrjanen, K. J., & Longatto Filho, A. (2017). High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
Citação norma ChicagoSilva, Estela Maria, Vânia Sammartino Mariano, Paula Roberta Aguiar Pastrez, Miguel Cordoba Pinto, António G. Castro, Kari Juhani Syrjanen, and Adhemar Longatto Filho. High Systemic IL-6 Is Associated with Worse Prognosis in Patients with Non-small Cell Lung Cancer. 2017.
Citação norma MLASilva, Estela Maria, et al. High Systemic IL-6 Is Associated with Worse Prognosis in Patients with Non-small Cell Lung Cancer. 2017.